Park M, Kim D, Ko S, Kim A, Mo K, Yoon H (2022) Breast cancer metastasis: mechanisms and therapeutic implications. Int J Mol Sci 23:6806. https://doi.org/10.3390/ijms23126806

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trayes KP, Cokenakes SEH (2021) Breast cancer treatment. Am Fam Physician 104:171–178

PubMed  Google Scholar 

Huang J, Chan PS, Lok V, Chen X, Ding H, Jin Y, Yuan J, Lao X-Q, Zheng Z-J, Wong MC (2021) Global incidence and mortality of breast cancer: a trend analysis. Aging 13:5748–5803. https://doi.org/10.18632/aging.202502

Article  PubMed  PubMed Central  Google Scholar 

Katsura C, Ogunmwonyi I, Kankam HK, Saha S (2022) Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond) 83:1–7. https://doi.org/10.12968/hmed.2021.0459

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–333. https://doi.org/10.3322/caac.21708

Article  PubMed  Google Scholar 

Orea-Soufi A, Paik J, Bragança J, Donlon TA, Willcox BJ, Link W (2022) FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol Sci 43:1070–1084. https://doi.org/10.1016/j.tips.2022.09.010

Article  CAS  PubMed  Google Scholar 

Farhan M, Wang H, Gaur U, Little PJ, Xu J, Zheng W (2017) FOXO signaling pathways as therapeutic targets in cancer. Int J Biol Sci 13:815–827. https://doi.org/10.7150/ijbs.20052

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zanella F, Santos NRD, Link W (2013) Moving to the core: spatiotemporal analysis of Forkhead box O (FOXO) and nuclear factor-κB (NF-κB) nuclear translocation. Traffic 14:247–258. https://doi.org/10.1111/tra.12034

Article  CAS  PubMed  Google Scholar 

Peng S, Li W, Hou N, Huang N (2020) A review of FOXO1-regulated metabolic diseases and related drug discoveries. Cells 9:184. https://doi.org/10.3390/cells9010184

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gui T, Burgering BMT (2022) FOXOs: masters of the equilibrium. FEBS J 289:7918–7939. https://doi.org/10.1111/febs.16221

Article  CAS  PubMed  Google Scholar 

Zou Y, Lin X, Bu J, Lin Z, Chen Y, Qiu Y, Mo H, Tang Y, Fang W, Wu Z (2020) Timeless-stimulated miR-5188-FOXO1/β-catenin-c-Jun feedback loop promotes stemness via ubiquitination of β-Catenin in breast cancer. Mol Ther 28:313–327. https://doi.org/10.1016/j.ymthe.2019.08.015

Article  CAS  PubMed  Google Scholar 

Parikh K, Cang S, Sekhri A, Liu D (2014) Selective inhibitors of nuclear export (SINE)—a novel class of anti-cancer agents. J Hematol Oncol 7:78. https://doi.org/10.1186/s13045-014-0078-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jimenez L, Mayoral-Varo V, Amenábar C, Ortega J, Sequeira JGN, Machuqueiro M, Mourato C, Silvestri R, Angeli A, Carta F, Supuran CT, Megías D, Ferreira BI, Link W (2022) Multiplexed cellular profiling identifies an organoselenium compound as an inhibitor of CRM1-mediated nuclear export. Traffic 23:587–599. https://doi.org/10.1111/tra.12872

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi Y, Xu S, Li S (2022) Selinexor improves the anti-cancer effect of tucidinostat on TP53 wild-type breast cancer. Mol Cell Endocrinol 545:111558. https://doi.org/10.1016/j.mce.2022.111558

Article  CAS  PubMed  Google Scholar 

Cautain B, Castillo F, Musso L, Ferreira BI, Pedro Nd, Quesada LR, Machado S, Vicente F, Dallavalle S, Link W (2016) Discovery of a novel, isothiazolonaphthoquinone-based small molecule activator of FOXO nuclear-cytoplasmic shuttling. PLoS ONE 11:e0167491. https://doi.org/10.1371/journal.pone.0167491

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uddin MH, Zonder JA, Azmi AS (2020) Exportin 1 inhibition as antiviral therapy. Drug Discov Today 25:1775–1781. https://doi.org/10.1016/j.drudis.2020.06.014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G (2022) Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 7:3. https://doi.org/10.1038/s41392-021-00762-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Varma K, Chauhan A, Bhargava M, Misra V, Srivastava S (2020) Association of different patterns of expression of beta-catenin and cyclin D1 with pathogenesis of breast carcinoma. Indian J Pathol Microbiol 63:13–18. https://doi.org/10.4103/IJPM.IJPM_419_19

Article  PubMed  Google Scholar 

Essers MAG, Vries-Smits LMMd, Barker N, Polderman PE, Burgering BMT, Korswagen HC (2005) Stress signaling functional interaction between -catenin and FOXO in oxidative. Science 308:1181–1184. https://doi.org/10.1126/science.1109083

Article  CAS  PubMed  Google Scholar 

Ip W, Chiang Y-TA, Jin T (2012) The involvement of the Wnt signaling pathway and TCF7L2 in diabetes mellitus: the current understanding, dispute, and perspective. Cell Biosci 2:28. https://doi.org/10.1186/2045-3701-2-28

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, Zhou Y, Liu Z, Liu Y, Hu Y, Xie Y, Fang W, Liu Z (2019) HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma. Theranostics 9:7583–7598. https://doi.org/10.7150/thno.37717

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guan H, Tan P, Xie L, Mi B, Fang Z, Li J, Yue J, Liao H, Li F (2015) FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression. Oncogenesis 7:e166. https://doi.org/10.1038/oncsis.2015.25

Article  CAS  Google Scholar 

Ling J, Wang F, Liu C, Dong X, Xue Y, Jia X, Song W, Li Q (2019) FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling. J Exp Clin Cancer Res 38:179. https://doi.org/10.1186/s13046-019-1174-3

Article  PubMed  PubMed Central  Google Scholar 

Zhang L-Y, Chen Y, Jia J, Zhu X, He Y, Wu L-M (2019) MiR-27a promotes EMT in ovarian cancer through active Wnt/. Cancer Biomark 24:31–42. https://doi.org/10.3233/CBM-181229

Article  CAS  PubMed  Google Scholar 

Wang Y, Wang Q, Li X, Luo G, Shen M, Shi J, Wang X, Tang L (2021) Paeoniflorin sensitizes breast cancer cells to tamoxifen by downregulating microRNA-15b via the FOXO1/CCND1/β-catenin axis. Drug Des Devel Ther 15:245–257. https://doi.org/10.2147/DDDT.S278002

Article  PubMed  PubMed Central  Google Scholar 

Tenbaum SP, Ordóñez-Morán P, Isabel Puig IC, Arqués O, Landolfi S, Fernández Y, Herance JR, Gispert JD, Mendizabal L, Aguilar S, Cajal SRY, Schwartz S Jr, Vivancos A, Espín E, Rojas S, Baselga J, Tabernero J, Muñoz A, Palmer HG (2012) β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 18:892–901. https://doi.org/10.1038/nm.2772

Article  CAS  PubMed  Google Scholar